Jonas M. Schneider

University Of Münster Wilhelm Klemm Straße 10 D-48149 Münster Germany
Muenster, NW 48149, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Effects of Faraday cup deterioration on Sr and Cr isotope analyses by thermal ionization mass spectrometry.

Effects of Faraday cup deterioration on Sr and Cr isotope analyses by thermal ionization mass spectrometry.

Journal: Journal of analytical atomic spectrometry

Published: April 23, 2024

Isotopic evidence for pallasite formation by impact mixing of olivine and metal during the first 10 million years of the Solar System.

Isotopic evidence for pallasite formation by impact mixing of olivine and metal during the first 10 million years of the Solar System.

Journal: PNAS nexus

Published: February 03, 2022

Anticoagulant treatment for venous thromboembolism: A pooled analysis and additional results of the XALIA and XALIA-LEA noninterventional studies.

Anticoagulant treatment for venous thromboembolism: A pooled analysis and additional results of the XALIA and XALIA-LEA noninterventional studies.

Journal: Research and practice in thrombosis and haemostasis

Published: August 13, 2020

XALIA-LEA: An observational study of venous thromboembolism treatment with rivaroxaban and standard anticoagulation in the Asia-Pacific, Eastern Europe, the Middle East, Africa and Latin America.

XALIA-LEA: An observational study of venous thromboembolism treatment with rivaroxaban and standard anticoagulation in the Asia-Pacific, Eastern Europe, the Middle East, Africa and Latin America.

Journal: Thrombosis research

Published: September 26, 2018

Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis.

Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis.

Journal: European journal of internal medicine

Published: June 22, 2018

Patient Management Strategies and Long-Term Outcomes in Isolated Distal Deep-Vein Thrombosis versus Proximal Deep-Vein Thrombosis: Findings from XALIA.

Patient Management Strategies and Long-Term Outcomes in Isolated Distal Deep-Vein Thrombosis versus Proximal Deep-Vein Thrombosis: Findings from XALIA.

Journal: TH open : companion journal to thrombosis and haemostasis

Published: June 13, 2018

Patient-Reported Treatment Experience with Oral Rivaroxaban: Results from the Noninterventional XALIA Study of Deep-Vein Thrombosis.

Patient-Reported Treatment Experience with Oral Rivaroxaban: Results from the Noninterventional XALIA Study of Deep-Vein Thrombosis.

Journal: TH open : companion journal to thrombosis and haemostasis

Published: September 29, 2017

Subgroup Analysis of Patients with Cancer in XALIA: A Noninterventional Study of Rivaroxaban versus Standard Anticoagulation for VTE.

Subgroup Analysis of Patients with Cancer in XALIA: A Noninterventional Study of Rivaroxaban versus Standard Anticoagulation for VTE.

Journal: TH open : companion journal to thrombosis and haemostasis

Published: June 28, 2017

Changes in oral anticoagulation for elective cardioversion: results from a European cardioversion registry.

Changes in oral anticoagulation for elective cardioversion: results from a European cardioversion registry.

Journal: European heart journal. Cardiovascular pharmacotherapy

Published: November 28, 2016

Analysis of patients with deep vein thrombosis switched from standard therapy to rivaroxaban in the non-interventional XALIA study.

Analysis of patients with deep vein thrombosis switched from standard therapy to rivaroxaban in the non-interventional XALIA study.

Journal: Thrombosis research

Published: November 16, 2016

Real life studies and good clinical practice - Authors' reply.

Real life studies and good clinical practice - Authors' reply.

Journal: The Lancet. Haematology

Published: February 19, 2016

Treatment of venous thromboembolism with rivaroxaban in relation to body weight. A sub-analysis of the EINSTEIN DVT/PE studies.

Treatment of venous thromboembolism with rivaroxaban in relation to body weight. A sub-analysis of the EINSTEIN DVT/PE studies.

Journal: Thrombosis and haemostasis

Published: February 03, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026